These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37283643)

  • 1. Dalbavancin in catheter-related bloodstream infections: a pilot study.
    Venturini S; Reffo I; Avolio M; Basaglia G; Del Fabro G; Callegari A; Grembiale A; Garlatti E; Castaldo V; Tonizzo M; Balbi M; Cevolani M; Basso B; Pellis T; Crapis M
    Infez Med; 2023; 31(2):250-256. PubMed ID: 37283643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of delayed catheter removal for patients with central-venous-catheter-related Gram-negative bacteraemia.
    Lee YM; Moon C; Kim YJ; Lee HJ; Lee MS; Park KH
    J Hosp Infect; 2018 May; 99(1):106-113. PubMed ID: 29330016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of distribution and drug resistance of pathogens isolated from 159 patients with catheter-related bloodstream infection in burn intensive care unit].
    Luo XQ; Gong YL; Zhang C; Liu MX; Shi YL; Peng YZ; Li N
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):24-31. PubMed ID: 32023714
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for peripherally inserted central catheterization-associated bloodstream infection in neonates.
    Xu YP; Shang ZR; Dorazio RM; Shi LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Feb; 24(2):141-146. PubMed ID: 35209978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
    Bouza E; Valerio M; Soriano A; Morata L; Carus EG; Rodríguez-González C; Hidalgo-Tenorio MC; Plata A; Muñoz P; Vena A;
    Int J Antimicrob Agents; 2018 Apr; 51(4):571-577. PubMed ID: 29180276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dalbavancin in the treatment of Gram-positive bacterial infections.
    Wang Y; Wang J; Wang R; Li Y; Cai Y
    J Glob Antimicrob Resist; 2021 Mar; 24():72-80. PubMed ID: 33279683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.
    Veve MP; Patel N; Smith ZA; Yeager SD; Wright LR; Shorman MA
    Int J Antimicrob Agents; 2020 Dec; 56(6):106210. PubMed ID: 33223119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019.
    Badia-Cebada L; Peñafiel J; Saliba P; Andrés M; Càmara J; Domenech D; Jiménez-Martínez E; Marrón A; Moreno E; Pomar V; Vaqué M; Limón E; Masats Ú; Pujol M; Gasch O;
    Euro Surveill; 2022 May; 27(19):. PubMed ID: 35551704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens.
    Raad I; Darouiche R; Vazquez J; Lentnek A; Hachem R; Hanna H; Goldstein B; Henkel T; Seltzer E
    Clin Infect Dis; 2005 Feb; 40(3):374-80. PubMed ID: 15668859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials.
    Gonzalez PL; Rappo U; Akinapelli K; McGregor JS; Puttagunta S; Dunne MW
    Infect Dis Ther; 2022 Feb; 11(1):423-434. PubMed ID: 34905144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI.
    Papavramidis T; Gentile I; Cattelan AM; Magnasco L; Viale P; Francisci D; Kofteridis DP; Tiseo G; Giamarellos-Bourboulis EJ; Lagi F; Pinna SM; D'Amico F; La Ferla L; Panagopoulos P; Gattuso G; Sipsas NV; Ruggieri A; Cattaneo A; Corio L; Comandini A; Mascagni P; Bassetti M
    Int J Antimicrob Agents; 2023 Apr; 61(4):106746. PubMed ID: 36758778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study.
    Saliba P; Hornero A; Cuervo G; Grau I; Jimenez E; García D; Tubau F; Martínez-Sánchez JM; Carratalà J; Pujol M
    J Hosp Infect; 2018 May; 99(1):48-54. PubMed ID: 29128346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients.
    Pitiriga V; Bakalis J; Theodoridou K; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Nov; 11(1):137. PubMed ID: 36352414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripherally inserted central catheter-related bloodstream infections in patients with hematological malignancies: A retrospective 7-years single-center study.
    Gao T; Zhu X; Zeng Q; Li X; Luo M; Yu C; Hu L; He J; Li Y; Yang Z; Yang H; Huang X; Gu X; Liu Z
    Am J Infect Control; 2022 Oct; 50(10):1171-1177. PubMed ID: 35108580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors of Central Venous Catheter-Related Bloodstream Infection for Continuous Renal Replacement Therapy in Kidney Intensive Care Unit Patients.
    Cheng S; Xu S; Guo J; He Q; Li A; Huang L; Liu Z; Li S
    Blood Purif; 2019; 48(2):175-182. PubMed ID: 30485840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of Catheter-Related Bloodstream Infections Between Tunneled Central Venous Catheters Versus Peripherally Inserted Central Catheters in Adult Home Parenteral Nutrition: A Meta-analysis.
    Hon K; Bihari S; Holt A; Bersten A; Kulkarni H
    JPEN J Parenter Enteral Nutr; 2019 Jan; 43(1):41-53. PubMed ID: 30035806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing catheter related bloodstream infection rate between cuffed tunnelled and non-cuffed tunnelled peripherally inserted central catheter.
    Sze Yong T; Vijayanathan AA; Chung E; Ng WL; Yaakup NA; Sulaiman N
    J Vasc Access; 2022 Mar; 23(2):225-231. PubMed ID: 33438482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter Salvage After Catheter-Related Bloodstream Infection During Home Parenteral Nutrition.
    Edakkanambeth Varayil J; Whitaker JA; Okano A; Carnell JJ; Davidson JB; Enzler MJ; Kelly DG; Mundi MS; Hurt RT
    JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):481-488. PubMed ID: 25972432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.